School of Advanced Agriculture Sciences, Peking University, Beijing 100871, China.
Department of Hepatobiliary Surgery, Xi-Jing Hospital, Fourth Military Medical University, Xi'an 710032, China.
ACS Nano. 2024 Oct 22;18(42):29152-29177. doi: 10.1021/acsnano.4c10725. Epub 2024 Oct 10.
Multivalent presentation of antigens using nanoparticles (NPs) as a platform is an effective strategy to enhance the immunogenicity of subunit vaccines and thus induce a high level of organismal immune response. Our previous results showed that pre-existing porcine circovirus type 2 (PCV2) antibodies could increase the antibody levels of nanoparticle vaccines carried in PCV2 VLPs. Here, we have established a generalized nanoantigen display platform, Cap-Cat virus-like particles (VLPs). By combining PCV2 VLPs with the modular linker element SpyTag003/SpyCatcher003 system, four porcine-derived viral protective antigens with different sizes and multimeric structures: the PRRSV B-cell epitope, the PEDV COE monomer, the CSFV E2 dimer, and the SIV HA trimer were efficiently demonstrated to elicit a strong immune response in mice. Crucially, the modification of antigens by the Cap-Cat VLPs platform enhanced the Th2 response and improved the Th1 response. The use of the platform demonstrates that HA antigen protects against lethal attacks by influenza viruses and reduces viral load in the lungs. We have demonstrated that the Cap-Cat VLPs platform demonstrates that antigens enhance the immune response by improving the processes of DC uptake, transport, lymph node (LN) localization, and immune cell activation. This "plug-and-display" assembly strategy facilitates the use of the Cap-Cat VLPs nanoantigen display platform for more applications and thus facilitates the development of more efficient, general-purpose porcine subunit vaccines.
多价抗原递呈使用纳米颗粒(NPs)作为平台是增强亚单位疫苗免疫原性并诱导高水平机体免疫反应的有效策略。我们之前的结果表明,猪圆环病毒 2 型(PCV2)的预先存在的抗体可以增加 PCV2 衣壳样颗粒(VLPs)中携带的纳米疫苗的抗体水平。在这里,我们建立了一个通用的纳米抗原展示平台,Cap-Cat 病毒样颗粒(VLPs)。通过将 PCV2 VLPs 与模块化接头元件 SpyTag003/SpyCatcher003 系统结合,四种不同大小和多聚体结构的猪源性病毒保护性抗原:PRRSV B 细胞表位、PEDV COE 单体、CSFV E2 二聚体和 SIV HA 三聚体被有效地证明可以在小鼠中引发强烈的免疫反应。至关重要的是,Cap-Cat VLPs 平台对抗原的修饰增强了 Th2 反应并改善了 Th1 反应。该平台的使用表明,HA 抗原可以抵抗流感病毒的致命攻击,并降低肺部的病毒载量。我们已经证明,Cap-Cat VLPs 平台通过改善 DC 摄取、运输、淋巴结(LN)定位和免疫细胞激活的过程来增强免疫反应。这种“即插即用”的组装策略有助于 Cap-Cat VLPs 纳米抗原展示平台的更多应用,从而促进更有效、通用的猪亚单位疫苗的开发。